Millennium Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
Millennium Management's CSTL Position: Q3 2026 in Review
Millennium Management increased its Castle Biosciences (CSTL) stake by 141% in Q3 2026, buying an estimated $8.76M and bringing the position to 495,633 shares worth $17.6M. The position accounts for 0.01% of the portfolio, ranked #1730.
Millennium Management first reported a position in CSTL in Q3 2019 and has held it in 27 quarters since. The position peaked at $32.5M in Q4 2020. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.
- Millennium Management held 495,633 shares of Castle Biosciences worth $17.6M as of Q3 2026.
- Millennium Management bought 290,264 Castle Biosciences shares in Q3 2026, an estimated $8.76M.
- Castle Biosciences made up 0.01% of Millennium Management's portfolio in Q3 2026, its #1730 holding.
- Millennium Management first reported a position in Castle Biosciences in Q3 2019 and has held it in 27 quarters since.
- Millennium Management's Castle Biosciences position peaked at $32.5M in Q4 2020.
- 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.